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Plasticity in the nervous system declines during ageing, 
as demonstrated by the progressive reduction in the 
ability of the central nervous system (CNS) to learn, to 
adapt to the changing environment and to compensate 
for damage. An outcome from this change in rodents is 
a progressive memory deficit detectable from around 12 
months [1] (and Yang et al. unpublished observations). 
Earlier in life plasticity is at a high level during the 
postnatal critical periods, then many forms of plasticity 
are reduced [2-4]. One of the key factors underlying this 
closure of critical periods is the formation of 
perineuronal nets (PNNs) together with other changes in 
the extracellular matrix (ECM) environment [5, 6].  
 
PNNs are specialized forms of ECM that condense 
around the surface of neurons at the end of the critical 
period, surrounding the synapses and blocking new 
synapse formation [6-10]. PNNs are composed of 
hyaluronan, tenascin, link proteins, and proteoglycans, 
the majority of which are chondroitin sulfate 
proteoglycans (CSPGs) [4, 11-13]. These consist of a 
core protein to which a number of chondroitin sulfate 
glycosaminoglycan chains (CS-GAGs) are attached. 
The most-studied type of PNN forms preferentially 
around parvalbumin fast-spiking GABAergic 
interneurons, where it acts to stabilize synaptic contacts, 
to limit further plasticity and to restrict the synaptic 
changes that underlie memory acquisition [4, 14, 15]. 
Various studies have shown that preventing PNN 
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Chondroitin sulfate (CS) proteoglycans in perineuronal nets (PNNs) from the central nervous system (CNS) are 
involved in the control of plasticity and memory. Removing PNNs reactivates plasticity and restores memory in 
models of Alzheimer’s disease and ageing. Their actions depend on the glycosaminoglycan (GAG) chains of CS 
proteoglycans, which are mainly sulfated in the 4 (C4S) or 6 (C6S) positions. While C4S is inhibitory, C6S is more 
permissive to axon growth, regeneration and plasticity. C6S decreases during critical period closure. We asked 
whether there is a late change in CS-GAG sulfation associated with memory loss in aged rats. 
Immunohistochemistry revealed a progressive increase in C4S and decrease in C6S from 3 to 18 months. GAGs 
extracted from brain PNNs showed a large reduction in C6S at 12 and 18 months, increasing the C4S/C6S ratio. 
There was no significant change in mRNA levels of the chondroitin sulfotransferases. PNN GAGs were more 
inhibitory to axon growth than those from the diffuse extracellular matrix. The 18-month PNN GAGs were more 
inhibitory than 3-month PNN GAGs. We suggest that the change in PNN GAG sulfation in aged brains renders 
the PNNs more inhibitory, which lead to a decrease in plasticity and adversely affect memory. 
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formation extends the critical period [5, 16] and 
removal of PNNs restores ocular dominance plasticity 
and other forms of plasticity back to the level seen 
during the critical period [6, 17]. More recently, it has 
also been demonstrated that the absence of PNNs 
increases terminal axonal sprouting, synaptic plasticity, 
and memory retention in adult mice and restores 
memory in an Alzheimer’s model [18, 19]. The 
mechanism by which PNNs control plasticity is still not 
clear; however, the observation that digestion of the CS-
GAG chains with chondroitinase ABC (chABC) 
restores plasticity to the adult CNS clearly implicates 
the CS-GAGs as effectors of the PNNs. PNNs may 
exert their inhibitory functions through binding and 
presentation of active molecules such as semaphorin 3A 
and OTX2[7, 20, 21], through effects on the mobility of 
ion channels [21, 22], through modulating inhibitory 
connections onto parvalbumin interneurons [10] and 
through interactions between GAGs and the receptor 
PTPsigma [23]. CS-GAGs in PNNs constitute 2% of 
total brain CS-GAG, and the other 98% also surround 
synapses and also have effects on synapse dynamics 
[24]. 
 
The pattern of sulfation on CS-GAGs defines their 
charge structure, binding affinities and biological 
functions, and sulfation patterns change during 
development [25, 26]. Chondroitin-6-sulfate (C6S also 
known as CS-C) is the major form during early 
development, but its level decreases progressively 
during development, and again with the closure of 
critical periods. As C6S decreases, chondroitin-4-sulfate 
(C4S also known as CS-A) progressively increases 
during maturation and with the closure of critical 
periods, and is the predominant CS form in the adult 
nervous system [5, 25, 27, 28]. Thus the ratio between 
C4S and C6S increases during the period of PNN 
formation and critical period closure particularly in the 
PNN fraction of the extracellular matrix [5, 29]. C4S 
and C6S differ in their effects on axon growth and 
plasticity. C4S is inhibitory for axon growth and 
regeneration [27], whereas C6S is much less inhibitory 
to neurite growth and animals deficient in the main 6-
sulfotransferase enzyme show greatly diminished 
plasticity and regeneration [30, 31]. High levels of C6S 
also inhibit PNN formation and restore ocular 
dominance plasticity in adult mice [31].  
 
Given the role of CS-GAGs in controlling plasticity in 
the developing nervous system, and the observation that 
the absence of PNNs enhances memory persistence in 
adult mice, we hypothesized that the progressive decline 
of memory and plasticity during aging could be partly 
driven by changes in the PNNs, particularly by sulfation 
changes in the CS-GAGs in the CNS which make PNNs 
more inhibitory to new synapse formation. In order to 
test this hypothesis, we have isolated and analyzed 
GAGs from the PNNs and from the general diffuse 
ECM from rats ranging from 3 to 18 months of age. Our 
results show a reduction of C6S leading to a large 
increase in the C4S/C6S ratio in the PNNs in 12- and 
18-month old brains. When extracted and tested for 
their ability to inhibit axon growth, the CS-GAGs from 
aged PNNs are more inhibitory to the growth of axons 
from adult dorsal root ganglia (DRG) than CS-GAGs 
from the PNNs of younger animals. The results provide 
the first evidence that the sulfation pattern of CS-GAGs 
in the PNNs changes with old age, and suggests that this 
change to more inhibitory PNNs might be a cause of 
memory deficits in old age. This is a new potential 
mechanism for memory loss in ageing, and is strongly 
supported by our current unpublished interventional 




Aged brains show an increase in C4S and a decrease 
in C6S  
 
To investigate the potential change in CS sulfation in 
aged brains, we first performed immunohistochemistry 
using antibodies targeting C4S and C6S on brain slices 
collected at different time points (Fig. 1). Brain slices of 
3-month (3m), 6-month (6m), 12-month (12m) and 18-
month old (18m) rats were stained with either LY111, 
an antibody which recognizes C4S GAG chains [32, 34, 
37], or MC21C, an antibody which recognizes the C6S 
disaccharide motif on GAG chains [34, 35]. These 
antibodies bind preferentially to the differently sulfated 
CS-GAGs, but their exact binding site is not fully 
defined and their binding is only moderately specific, 
however they are currently the best available.  
 
The staining intensity of brain sections was quantified 
by densitometry, with measurements taken from the 
auditory, visual and motor cortices. Staining intensity of 
C4S increased with age in the auditory cortex 
(representative images are shown in Fig. 1A), in the 
visual cortex, and in the motor cortex. Measurement of 
staining intensity in these areas showed a significant 
increase in C4S with ageing (Fig. 1B. 3m: 2.943 ± 
0.069; 6m: 5.203 ± 0.118; 12m: 5.507± 0.147; 18m: 
6.459± 0.138; Kruskal Wallis: p < 0.001. Data are 
averages of all the cortical areas analyzed). Conversely, 
the staining intensity of C6S decreased with age in the 
auditory cortex (representative images are shown in Fig. 
1C), in the visual cortex, and in the motor cortex. 
Statistics done on cumulative averages of the areas 
showed a significant decrease in staining intensity (Fig. 
1D. 3m = 4.848 ± 0.438; 6m = 4.628± 0.163; 12m = 
4.186± 0.150; 18m = 3.034 ± 0.124; Kruskal Wallis: p < 
0.001. Data are averages of all the cortical areas 
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analyzed).  This experiment suggests that the overall 
level of C4S increases in several brain regions during 
ageing, whereas C6S decreases. 
 
The reduction of C6S is specific to the PNNs from 
older animals 
 
Immunohistochemistry showed a trend of C4S increase 
and C6S reduction in ageing brains. We needed to 
measure sulfation changes in the CNS with a more 
robust method, and to investigate if the change in CS 
sulfation is a general phenomenon in the brain matrix or 
is specifically associated with the PNNs. This was done 
by sulfation analysis from sequential extraction of 
GAGs from the different matrix compartments of rat 
brains using a method validated in our previous 
publications [36, 38]. GAGs from the general diffuse 
ECM are extracted in buffer 1 (B1, physiological 
saline), GAGs from membrane-associated matrix and 
cytoplasmic molecules are extracted in buffer 2 (B2, 
with detergent), charged matrix molecules are retained 
in buffer 3 (B3, 1 M sodium chloride), and GAGs from 
highly stable condensed matrix (~2% of total GAG in 
the brain) are finally retained in buffer 4 (B4, 6 M urea). 
The method provides an enrichment of PNN GAGs in 
B4 [38, 39]. GAGs isolated using this method were 
digested with chABC and the resulting disaccharides in 
fractions B1 and B4 were analyzed using fluorophore-
assisted carbohydrate electrophoresis (FACE) for age-
dependent changes in CS sulfation.  
 
We first asked whether the total GAG content isolated 
from the brain changes upon ageing. Fig. 2A shows that 
the total quantity of GAGs isolated from the general 
diffuse brain matrix (B1) and PNN matrix (B4) are 
stable; no age related changes were observed at any of 
the time points analyzed. We then proceeded to analyze 
the specific CS sulfation patterns, and in particular the 
level of C4S and C6S disaccharides (Fig. 2B) using 
FACE. The results confirm previous results showing 
that, in the mature brain, C4S is the major CS sulfation 
isoform (Fig.2, C-F) while C6S is present at a much 
lower level (Fig. 3, B-C). This observation is consistent 
for both GAGs isolated from the general ECM (Fig. 2, 
C and D; Fig. 3, A and B) and the PNN fraction (Fig. 2, 
E and F; Fig. 3, A and C). The sulfation pattern of the 
diffuse ECM fraction (B1) remained stable with ageing 
(Fig. 2D and 3B). The amount of C4S remained 
constant from 3 to 18 months (Fig. 2D. 3m: 108.623 ± 
8.655; 6m: 95.448 ± 9.206; 12m: 104.970 ± 9.049; 18m: 
101.968 ± 3.487); similarly, also the amount of C6S did 
not change significantly over time (the apparent 
decreasing trend was not significant) (Fig. 3B, right 
graph. 3m: 18.235 ± 5.218; 6m: 13.816 ± 3.107; 12m: 
17.411 ± 3.407; 18m: 10.954 ± 3.211). In contrast, in 
the PNNs fraction (B4; Fig. 2E and F) the amount of 
 
 
Figure 1. Brain immunohistochemistry shows a progressive increase in C4S and a progressive decrease in C6S from 3 to 
18 months of age.  (A) Immunostaining of the auditory cortex with antibody LY111, which recognizes C4S, at time points 3 months to 
18 months. (B) The histogram shows the quantification of the staining intensity of C4S from 3 to 18 months. (C) Immunostaining of the 
auditory cortex with antibody MC21C, which recognizes C6S, at time points 3 months to 18 months. (D) The histogram shows the 
quantification of the staining intensity of C6S from 3 to 18 months. Graphs show mean ± s.e.m. *** indicates a significant relationship 
between staining intensity and time by Kruskal Wallis, p >0.001. 3m, 3-month-old brains; 6m, 6-month-old brains; 12m, 12-month-old 
brains; 18m, 18-month-old brains; C4S, Chondroitin-4-sulfate; C6S, Chondroitin-6-sulfate. Scale bars: 200 µm. 
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C4S showed a non-significant tendency to increase with 
ageing (Fig. 2F. 3m: 73.306 ± 5.271; 6m: 60.955 ± 
6.151; 12m: 82.715 ± 11.439; 18m: 89.721 ± 11.203); 
whereas we observed a reduction of C6S in the PNNs 
fraction from aged brains at 12 and 18 months (Fig. 3C. 
3m: 15.256 ± 1.582; 6m: 14.364 ± 1.409; 12m: 5.749 ± 
1.540; 18m: 6.252 ± 1.666; One Way ANOVA: p < 
0.001; Bonferroni post-hoc comparisons significant for 
3m vs 12m and 18m, and for 6m vs 12m and 18m). This 
constitutes a 60% reduction of C6S from young (3m 
and 6m) to old (12m and 18m) PNN GAG samples. 
 
As effects on plasticity and regeneration are probably 
determined by the ratio of inhibitory C4S to permissive 
 
 
Figure 2. Biochemical analyses of CS-GAG sulfation.  12-, 18-month old brains shows an increase in the ratio C4S/C6S in 
the PNNs fraction. (A) Measurement of the total CS GAGs quantity in the various fractions extracted from brains at time points from 
3 to 18 months. There is no overall change in GAGs quantity with time. (B) The structure of the repeating disaccharide making up CS 
GAGs. The left diagram is sulfated in the 4 position (C4S), the right in the 6 position (C6S). (C) A composite image representing examples 
of FACE gels with CS GAGs extracted from the diffuse (B1) ECM at 3,6, 12 and 18 months. The GAGs were digested into disaccharides 
using chABC and the resulting disaccharides were electrophoresed in the FACE gel. The C4S disaccharides were identified by comparing 
the band location to the standard disaccharides in the first and last lanes. (D) Quantification of the FACE gels from the lower part of the 
sulfated band. C4S remains stable over time. (E) A composite image representing examples of FACE gels of CS GAGs extracted from the 
PNNs (B4) fraction at 3,6, 12 and 18 months. (F) There is a non-significant trend of an increase in C4S over time.  
Graphs show mean ± s.e.m. *** indicates a significant relationship between the considered CS GAGs and time by One Way Anova, p 
>0.001.** indicates a significant relationship between the considered ratio and time by Kruskal-Wallis test, p =0.002.B1, ECM fraction; 
B4, PNNs fraction; B1+B2+B3+B4, sum of GAGs from the four fractions of each brain; 3m, 3-month-old brains; 6m, 6-month-old brains; 
12m, 12-month-old brains; 18m, 18-month-old brains; C4S, Chondroitin-4-sulfate; C6S, Chondroitin-6-sulfate; C0S, Chondroitin non-
sulfated; HA, hyaluronic acid. 
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C6S, we looked at the ratio between C4S and C6S in the 
different fractions. In the diffuse ECM (B1), this ratio 
remained unchanged from 3 to 18 months (Fig. 3D, left 
graph. 3m: 7.996 ± 1.909; 6m: 8.371 ± 1.684; 12m: 
7.160 ± 1.556; 18m: 12.336 ± 2.656). In contrast, in 
PNN extracts (B4), the ratio C4S/C6S increased 
significantly with age (Fig. 3D, right graph. 3m: 4.898 ± 
0.335; 6m: 4.329 ± 0.400; 12m: 22.620 ± 10.540; 18m: 
18.935 ± 5.112; Kruskal-Wallis: p = 0.002.). This 
means that between the young samples (3 m and 6 m) 
and the old samples (12 m and 18 m) the ratio C4S/C6S 
increased by more than 300%.  
 
In conclusion, the biochemical results from glycan 
analysis show that the relative quantities of mono-
sulfated disaccharides change in favor of the inhibitory 
 
 
Figure 3. Quantification of C6S after chondro-6-sulfatase digestion. (A) A composite picture taken from two gels, one with 
buffer 1 and the other with buffer 4. Each extract shows the ChABC digested lane and the same extracted digested with chondro-6-
sulfatase. (B and C) Quantification of C6S levels in buffer 1 and buffer 4 extract. There is a significant reduction in C6S at 12m and 18m 
time points in buffer 4 fractions. (D) The ratio of C4S to C6S at the four time points, plotted respectively from the data in figure 2 and 3. 
The ratio significantly increases in favor of the inhibitory C4S in 12 and 18 months PNNs extracts. 
Graphs show mean ± s.e.m. *** indicates a significant relationship between the considered CS GAGs and time by One Way Anova, p 
>0.001.** indicates a significant relationship between the considered ratio and time by Kruskal-Wallis test, p =0.002.B1, ECM fraction; 
B4, PNNs fraction; B1+B2+B3+B4, sum of GAGs from the four fractions of each brain; 3m, 3-month-old brains; 6m, 6-month-old brains; 
12m, 12-month-old brains; 18m, 18-month-old brains; C4S, Chondroitin-4-sulfate; C6S, Chondroitin-6-sulfate; C0S, Chondroitin non-
sulfated; HA, hyaluronic acid. 
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C4S upon ageing, mainly due to a decrease in C6S at 12 
and 18 months, and this change occurs specifically in 
the PNNs fraction. This change may make aged PNNs 
more inhibitory. 
 
The changes in PNNs sulfation pattern are not due 
to a change in overall gene expression 
 
The most straightforward possibility to explain changes 
in the GAGs sulfation pattern would be a change in the 
expression of the genes regulating the synthesis of 
different sulfated groups. In mammals, C4S can be 
produced by three sulfotransferases isoforms, 
transcribed from Chst11, Chst12, and Chst13 
respectively [40, 41]. Formation of C6S is instead 
dependent on the sulfotransferases Chst3 and Chst7 [42, 
43]. The mRNA levels of some of these enzymes 
change after brain injury [28]. We analyzed the 
expression of these genes in the somatosensory cortex 
of rats from 3 to 18 months of age to test whether gene 
regulation may account for the observed changes in 
PNNs sulfation. 
 
In the whole brain samples no changes in 
sulfotransferase mRNA expression with ageing were 
seen (Fig. 4). However, in our glycan sulfation 
measurements we saw changes in sulfation levels with 
age only in the PNN fraction, and this represents only 
2% of total brain CSPGs. No sulfation changes were 
seen in the large majority of CSPGs making up the 
diffuse matrix. It is therefore not surprising that overall 
sulfotransferase mRNA levels did not change. It is 
possible that specific changes in sulfotransferase mRNA 
levels restricted to PV interneurons occur, but these 
changes would not have been detected by our assay. 
 
 
Figure 4. mRNA levels for the various chondroitin sulfotransferases do not change with ageing.  (A) shows typical PCR 
results for the various enzymes. The age of brain from which the mRNAs were extracted is shown by bars at the bottom. The number of 
cycles is shown by the number above each gel. (B) Quantification of the mRNA levels for the sulfotransferases at 4 age points. The 
method of quantification is described in the methods section. There are no changes of mRNA levels with ageing. Each bar represents 
results from at least 4 assays. Bars are SEM.  
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PNNs extracts from 18-month-old rats are more 
inhibitory for neurite growth than PNNs extracts 
from 3-month-old rats 
 
To assess whether the age-related change in CS 
sulfation in the PNNs would result in stronger inhibition 
to neurite outgrowth, we cultured adult DRG neurons 
on coverslips coated with the GAG extracts from 
different ages and fractions. This assay is a proven and 
sensitive method for assessing inhibition due to 
proteoglycans in general and CS in particular [44, 45]. 
The results were quantified by measuring the longest 
axon for each individual DRG neuron and averaging 
120-180 neurons from three repeats of each condition. 
DRG neurons cultured on laminin alone showed 
extensive healthy neurite projections, with an average 
length of 402.105 ± 8.531 µm (Fig. 5C). All neurons 
cultured on isolated GAGs projected shorter neurites 
than when cultured on laminin, demonstrating the 
overall inhibitory nature of the isolated GAGs to 
neuronal growth (Fig.5E. One Way ANOVA and 
Dunnett post-hoc: p < 0.001 for every comparison). A 
comparison of the neurite length from DRGs cultured 
on different GAGs fractions of the same age showed 
that PNN extracts (B4; Fig. 5B) were always more 
inhibitory than diffuse ECM extracts (B1; Fig. 5A), 
with a more marked difference at the 18-month time-
point, where PNN GAGs showed much more inhibition 
than at 3 months. Comparison between diffuse ECM 
(B1) and PNN (B4) GAGs from 3-month brains showed 
22% less growth on PNN GAGs (Fig. 5: compare the 
left picture from panel A with the left picture from 
panel B; Fig. 5E. Average longest neurite on ECM: 
256.221 ± 10.578µm; average longest neurite on PNNs: 
 
 
Figure 5. Axon growth in vitro is inhibited by GAGs, and more inhibited when GAGs are from PNNs fractions of old 
brains.  (A) Axon outgrowth from adult DRG neurons plated on laminin mixed with CS GAGs from diffuse ECM fraction (B1) of 3 or 18 
month old brains. (B) Axon outgrowth from adult DRG neurons plated on laminin mixed with CS GAGs from PNN fraction (B4) of 3 or 18 
month old brains. (C) Axon outgrowth from typical adult DRG neurons plated on laminin on laminin alone. (D) Axon outgrowth from 
adult DRG neurons plated on laminin mixed with CS GAGs from PNN fraction of 18 months brains (B4) and treated with chABC. (E) The 
graph shows average longest neurite of DRG grown 24 h on each plating condition. All the GAGs inhibit neurite outgrowth when 
compared with laminin alone; PNNs extracts are more inhibitory than ECM extracts; growth is further reduced when GAGs are from the 
PNNs fraction of aged brains; chABC treatment partially rescues the inhibitory effect of PNNs extracts from 18 months brains.  
Graphs show mean ± s.e.m. Asterisks indicate a significant relationship between average longest neurite and type of GAGs extract used 
for plating. One Way Anova and Dunnett post-hoc comparisons:***p >0.001, **p =0.002.B1, ECM fraction; B4, PNNs fraction; 3m, 3-
month-old brains; 6m, 6-month-old brains; 12m, 12-month-old brains; 18m, 18-month-old brains; C4S, Chondroitin-4-sulfate; C6S, 
Chondroitin-6-sulfate; lam, laminin; chABC, chondroitinase ABC. Scale bar: 100 µm. 
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199.193 ± 9.051 µm; Dunnett post-hoc: p = 0.002). 
Comparison between diffuse ECM (B1) and PNN (B4) 
GAGs from 18-month brains showed a difference of 
over 60% (Fig 5: compare the right picture from panel 
A with the right picture from panel B; Fig. 5E. Average 
longest neurite on ECM: 230.777 ± 12.568 µm; average 
longest neurite on PNNs: 84.386 ± 5.604 µm; Dunnett 
post-hoc: p < 0.001). Moreover, inhibition from the 
GAGs increased with age in the PNN fraction (B4; Fig. 
5, B and E), but not in the diffuse ECM fraction (B1; 
Fig. 5, A and E). In the diffuse ECM assays (B1), axon 
growth was the same regardless the age of the extracts 
(Fig. 5: compare the two pictures in panel A; Fig. 5E. 
Average longest neurite on 3m B1 extracts: 256.221 ± 
10.578 µm; average longest neurite on 18m B1 extracts: 
230.777 ± 12.568 µm). However in the PNN extracts 
(B4), the inhibitory effect of 18-month extracts was 
58% greater than that of the 3-month PNN extracts (Fig. 
5: compare the two pictures in panel B; Fig. 5E. 
Average longest neurite on 3m B4: 199.193 ± 9.051 
µm; average longest neurite on 18m B4: 84.386 ± 5.604 
µm; Dunnett post-hoc: p < 0.001). To further confirm 
that the inhibition of axon growth was due to CS-GAGs, 
we performed a set of experiments treating the 
coverslips with the enzyme chondroitinase ABC 
(chABC) after GAG coating, in order to digest the CSs 
and remove their inhibition. We applied the enzymatic 
treatment on samples from the 3- and 18-month PNNs 
fraction (B4). We obtained a significant rescue of about 
29% in 3-months and 57% in 18-months (Fig. 5: 
compare the right picture of panel B with the picture D; 
Fig. 5E. Average longest neurite on 3m B4 extracts: 
196.812 ± 4.923 µm; average longest neurite on 3m B4 
+ chABC: 252.194 ± 7.461 µm; average longest neurite 
on 18m B4 extracts: 84.386 ± 5.604 µm; average 
longest neurite on 18m B4 + chABC: 132.356 ± 7.263 
µm; Dunnett post-hoc: p = 0.001).  
 
Overall, these results demonstrated that GAGs from the 
PNN extracts (B4) are considerably more inhibitory 
than those from the diffuse ECM (B1). Moreover, PNN 
GAGs become much more inhibitory with age, while 
diffuse ECM GAGs do not. This is a large effect for 
PNN GAGs, with DRG neurons grown on PNN fraction 
of 18-month-old brains having axons 80% shorter than 
when neurons are grown on laminin alone. This strong 
inhibitory effect is mainly due to the specific CSs 
present in the GAGs extracts, since eliminating CSs 




Our hypothesis was that the decline in memory and 
plasticity in the ageing brain might be explained or 
correlated with changes in the brain ECM, particularly 
in the matrix composing PNNs. We have therefore 
examined ageing changes in the CS-GAGs because 
these sulfated chains are critically involved in 
determining the function of PNNs and in the control of 
memory and plasticity. Here, we demonstrate that CS-
GAGs in the PNNs change with ageing, with a fall in 
C6S leading to an increase in the ratio between C4S and 
C6S. This change is functionally significant, because 
GAGs extracted from PNNs extracts become much 
more inhibitory to axon growth with ageing. 
Interestingly, there was no ageing change in the 
sulfation pattern of the CS-GAGs from the diffuse brain 
ECM, which makes up the great majority of brain CS-
GAG. This diffuse ECM surrounds synapses and 
certainly plays a part in regulating their dynamics, but 
our findings reinforce the idea that PNNs have a 
specific regulatory function in plasticity and memory. 
 
Old age is connected with a decline in many brain 
functions even in healthy individuals, with a predictable 
loss of memory function even in those who do not 
develop Alzheimer’s disease.  The physiological 
mechanisms behind the decline in CNS function with 
ageing are still incompletely understood. Our previous 
work has demonstrated a link between CS-GAGs, 
PNNs, plasticity and memory [18, 19, 46]. Thus 
digesting brain CS-GAGs or removing PNNs can 
extend memory in normal rodents, or restore memory in 
models of Alzheimer’s disease and ageing [18, 19] 
(Yang et al. unpublished observations). A possible 
hypothesis for the loss of memory in ageing is therefore 
that there might be an event that changes the properties 
of PNNs in the aged brain. One way of reducing brain 
plasticity is to reduce the amount of 6-sulfated CS 
GAG; this was demonstrated by creating a knockout 
mouse lacking the Chst3 sulfotransferase, leading to an 
animal with much reduced plasticity and CNS axon 
regeneration [30]. Conversely, overexpression of Chst3 
restores plasticity in the adult CNS [31]. Therefore, the 
results reported here are consistent the hypothesis that 
the ageing nervous system loses memory through the 
loss of C6S GAGs in PNNs.  
 
PNNs around inhibitory GABAergic parvalbumin 
neurons are compact ECM structures composed of 
hyaluronic acid, tenascins, link proteins and 
proteoglycans, especially CSPGs [4, 11, 47]. These 
molecules are upregulated at the end of critical periods 
for plasticity and condense around the parvalbumin 
neurons, where they stabilize synapses and limit further 
plasticity [5, 6, 10, 48]. There are different aggrecan-
based nets around other classes of neuron [49, 50]. 
Several studies have demonstrated a developmental 
regulation of C4S and C6S on total CS-GAGs extracts 
from the embryonic to early adult CNS. C4S is not only 
the most abundant disaccharide in the adult CNS, but 
also its relative quantity compared to C6S increases 
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from embryos to adults. On the contrary, C6S is 
expressed at a high level at embryonic stages, but 
greatly downregulated in adulthood at the end of critical 
periods [5, 25, 28]. Interestingly, the resulting shift in 
the C4S/C6S ratio has recently been suggested as 
possible trigger of PNNs formation and critical period 
closure [29, 31]. Moreover, C4S has been shown to be 
more inhibitory than C6S [27, 30]. These known 
changes were an origin of our hypothesis that the 
relative quantities of C4S and C6S on the PNNs might 
change with ageing, thus rendering the environment of 
the aged brain progressively more inhibitory and less 
able to support memory and plasticity. 
 
In order to study the relative quantities of C4S and C6S 
in the ageing rat brain, we first studied the distribution 
of C4S and C6S in the brains using 
immunohistochemistry. We decided to focus on three 
cortical areas in which PNNs formation clearly 
coincides with the end of the critical period and in 
which the formation of PNNs has been shown to inhibit 
subsequent plasticity, i.e. the motor cortex [51], the 
auditory cortex [52, 53] and the visual cortex [6]. In 
these cortical areas, our immunostaining results showed 
a consistent increase in C4S and a consistent decrease in 
C6S from 3 months to 18 months of age. However, the 
antibodies used in this study have partly-defined 
binding targets, and it is not known if they bind to the 
whole CS-GAG chain or just its terminal residues. We 
therefore did a biochemical analysis of sulfation of CS-
GAGs in the ageing brain.  
 
In previous work, we have asked whether the control of 
plasticity is due to CS-GAGs in the general diffuse 
ECM found throughout the brain, or whether it is the 
approximately 2% of CS-GAGs contained within PNNs 
that is responsible. A brain knockout of the PNN 
component Crtl1 link protein led to attenuated PNNs 
without any overall change in the quantity of brain CS-
GAGs, yet these animals showed continuing plasticity 
with no closure of their critical periods [5]. This 
demonstrates that PNNs are the specific ECM structures 
involved in the regulation of this form of adult 
plasticity. Similarly, these animals with attenuated 
PNNs show a prolongation of object recognition 
memory, identically to animals in which all brain CS-
GAG is digested with chABC [18]. These results focus 
attention on CS-GAGs in PNNs rather than in the 
diffuse matrix. It was therefore important in the present 
investigation to analyze GAGs modifications 
specifically in the PNNs as well as in the diffuse ECM. 
To this aim, we analyzed the CS GAGs isolated from 
the diffuse ECM and from the PNNs using the 
sequential extraction method [38, 39]. The procedure 
separates GAGs contained in different ECM structures: 
B1 –diffuse ECM, B4 – stable aggregated ECM 
including PNNs. In line with previous literature on adult 
GAGs, our results confirmed a higher level of C4S 
compared to C6S in the brain ECM [5, 28, 31, 38]. Our 
new result is that the levels of C4S and C6S in the 
PNNs continue to change upon ageing, with a very 
significant decrease in C6S and a tendency of increase 
for C4S. This leads to a large shift in the C4S/C6S ratio, 
particularly at 12 and 18 months of age in rats; at this 
same age mice show profound memory deficits [1] 
Yang et al., unpublished observations). However, these 
changes were restricted to the PNNs fraction and were 
not seen in the diffuse ECM. This result suggests that 
PNNs become more inhibitory in the aged brain due to 
an increase in the ratio of inhibitory C4S over the more 
permissive C6S.  
 
Our biochemical results show no change of C4S during 
ageing while immunohistochemistry showed an 
increase in C4S. This discrepancy of results is likely 
due to the cross-interaction of the LY111 antibody to 
other types of chondroitin sulfations. The structural 
similarity of different sulfation forms are strikingly high 
and it is difficult to raise antibody to be specific to one 
form only. When other sulfation is present in high 
concentration, it is likely that the antibody will bind to 
these sulfation too. Unpublished data from the lab 
showed that LY-111 binds to CS-C, -D and -E at high 
concentration in dot blot assay. 
 
To demonstrate directly that CS GAGs from PNNs 
become more inhibitory in the aged brain, we used  a 
functional assay in which dissociated adult DRG 
neurons were grown on a mixed surface of laminin and 
CS-GAGs extracted from the brain at different ages. 
DRG neurons are very responsive to changes in 
extracellular environment, including the inhibition from 
CS proteoglycans [44, 45, 54]. We compared the 
growth of DRG neurites on GAG extracts from diffuse 
ECM (B1) and PNNs (B4) at the youngest (3m) and the 
oldest (18m) time points. GAGs from the PNNs were 
more inhibitory than GAGs from the diffuse ECM at 
both time points, supporting the hypothesis that PNNs 
are a specialized inhibitory structure of the ECM [5]. 
Importantly, the growth of DRG neurons was inhibited 
the most strongly by the PNN GAGs extracted from 
aged 18-month-old brains, while the inhibition was 
much less using PNN GAGs isolated from young rats. 
We suggest this age-related increase in inhibition is due 
to the loss of 6-sulfated GAGs in the PNN fraction. 
There was no change in 6-sulfation in the diffuse matrix 
and this did not show an age-related increase in 
inhibition of axon growth.  Chondroitinase treatment 
partially rescued the growth of neurites from the old 
brains. This suggests that there are other glycan 
structures in the 18-month old GAG preparation which 
are conferring inhibition to DRG neurons. However, the 
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result is sufficient to indicate and confirm that changes 
in CS sulfation confer a more inhibitory property to the 
aged PNNs.  
 
Sulfation levels are determined by the activity of 
sulfotransferases, Chst11, Chst12, Chst13, Chst3, and 
Chst7 being the main 4 and 6- sulfotransferases. Several 
of these genes are regulated following CNS damage 
[28]. We measured mRNA levels for these enzymes in 
whole brain at different ages, finding no changes. This 
result probably reflects the absence of change in 
sulfation of the CS-GAGs in the diffuse ECM, which 
make up the great majority of the CS-GAG in the brain. 
It is possible that there were mRNA changes in the PV 
interneurons which produce 2% of CS-GAG that would 
not have been revealed by this assay. Although the 
changes in Chst expression are minimal, we have 
previously demonstrated that the small changes in 
sulfations are crucial in determining the binding 
properties of PNNs to semaphorin 3A and Otx2 [7, 20, 
21]. 
 
In conclusion, our study demonstrates for the first time 
that PNNs become progressively more inhibitory during 
ageing, and that this is at least partly attributable to a 
shift in the degree of C4S and C6S sulfation. We 
hypothesize that these changes in PNNs lead to a loss of 
plasticity and memory in the aged brain, an idea 
strongly supported by our current work (Yang et al. 
unpublished observations). Modulation of PNN 
sulfation is therefore an interesting new target for 
restoration of memory in the aged brain.   
 




Sprague Dawley rats (Charles River) of 3-month-old 
(3m), 6-month-old (6m), 12-month-old (12m), 18-
month-old (18m) were used for the experiments. 
Animals undergoing perfusion were anaesthetized with 
raising concentration of CO2 followed by terminal 
injection of Euthatal (1ml per 300g of weight). 
Collection of fresh tissues was performed after raising 
concentration of CO2 followed by cervical dislocation. 
All experiments were performed according to the 
“Animal (Scientific Procedures) Act 1986” and the 
“Guidance of the Operation of ASPA 2014”, and were 





Rats were perfused with 0.12 M phosphate buffer 
followed by 500 ml of 4% paraformaldehyde. Brains 
were dissected and post-fixed in the same fixative 
overnight at 4°C, then cryoprotected in 30% sucrose in 
0.12 M phosphate buffer. 30-µm-thick coronal sections 
were cut using a sledge microtome and collected in 1X 
PBS. All incubations were done at room temperature in 
1X PBS with 0.3% Triton X-100 and 0.02% sodium 
azide plus 10% donkey serum. Free-floating sections 
were incubated overnight with shaking in one of the 
following antibodies or binding proteins: biotinylated 
Wisteria Floribunda agglutinin (Sigma, 20 µg/ml), 
mouse anti-C4S IgM antibody (clone: LY111; 
Seikagaku, 1:500), mouse anti-C6S IgM antibody 
(clone: MC21C; Seikagaku, 1:500). After rinsing, slices 
were incubated for 1 h with biotinylated anti-mouse 
IgM antibody (Jackson Lab, 1:200) where needed and 
followed by 1 h incubation with Alexa Fluor 647-
conjugated streptavidin (Invitrogen, 1:1000). All the 
sections were then rinsed and stained overnight with 
rabbit anti-parvalbumin antibody (Swant, 1:1000), 
followed by 1 h incubation with Alexa Fluor 568-
conjugated anti-rabbit antibody (Invitrogen, 1:1000).  
 
Fixed DRG cultures (on coverslips) were washed in 1X 
PBS with 0.3% Triton X-100 and 0.02% sodium azide, 
then incubated in PBS with 0.3% Triton X-100, 0.02% 
sodium azide and 5% normal donkey serum for 1 h. 
Coverslips were incubated for 2 h with rabbit anti-3-
tubulin antibody (Sigma, 1:400), mouse anti-CS IgM 
antibody (clone CS56; Sigma, 1:400), FITC-conjugate 
IB4 (Sigma, 1:200). After rinsing, the coverslips were 
incubated with secondary antibodies: biotinylated anti-
mouse IgM (Jackson Lab, 1:250), Alexa Fluor 568-
conjugated anti-rabbit antibody (1:400), Alexa Fluor 
647-conjugated streptavidin (1:400), and counter stain 
with Hoechst 33342 (Roche; 1:10,000) for 1 h.  
 
Slides or coverslips were mounted with FluoroSave 
(Calbiochem) and visualized with a Leica DM6000B 
epifluorescence microscope or with a Leica SPE1000 
confocal microscope. Images were taken by keeping the 




Previous literature has demonstrated that that LY111 
stains specifically for C4S motif [32, 33] and that 
MC21C stains specifically for C6S motif [34, 35]. 
Densitometry analysis of LY111 and MC21C was 
performed in different areas in the cortex, including 
motor, visual and auditory cortices. 3 to 6 rats were 
used per time point. For each brain area, 3-8 images 
were taken at 10X magnification. Mean grey value data 
were quantified with ImageJ on an arbitrary scale 0-
255, where 0 is a pixel with no signal and 255 is a pixel 
of the maximum intensity (i.e. saturated). For each 
picture, mean grey value of a stained area was 
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normalized against mean grey value of an unstained 
area of the same image (background). Data are shown in 




Biochemical analyses were performed on 5 animals at 
each age. Sequential extraction of GAGs from rat brains 
was performed following a modified protocol from [36]. 
Briefly, fresh frozen brains were first homogenized very 
gently in buffer 1 [B1: 50 mM Tris-buffered saline 
(TBS), 2 mM ethylenediamine tetraacetic acid (EDTA), 
and Complete Mini EDTA-free protease inhibitor 
cocktail (Roche)] using Potter-Elvehjem. Homogenates 
were centrifuged at 4°C and 23,000 xg for 20 min, 
supernatant collected, pellets resuspended in B1 and 
centrifuged again; supernatants from the two 
centrifugations were pooled. Subsequently, pellets were 
resuspended in buffer 2 (B2: 0.5% Triton X-100 in B1 
plus protease inhibitor) and centrifuged twice, then in 
buffer 3 (B3: 1 M sodium chloride in B2 plus protease 
inhibitor) and centrifuged twice, then finally in buffer 4 
(B4: 6 M urea in B2 plus protease inhibitor) and 
centrifuged twice. Supernatants from each buffer were 
dialyzed in 25 mM Tris-HCl and 5 mM EDTA pH 8.0 
overnight at 4°C using 3.5K MWCO dialysis tubing 
(Thermo Scientific). Thereafter, samples were incubated 
overnight at 37°C with 200 mg/ml pronase (Roche). 
The following day, samples were centrifuged at 4°C and 
23,000 xg for 20 min, supernatants were collected and 
proteins were precipitated with 5% trichloroacetic acid 
(TCA) for 1 h on ice. Samples were centrifuged at 4°C 
and 23,000 xg for 20 min, supernatants were collected 
and the pellets were washed with 5% TCA. 
Supernatants were then washed four times in 1:1 diethyl 
ether, which was subsequently evaporated overnight. 
Samples were then neutralized to pH 7.0 with 1 M 
sodium bicarbonate solution. The GAGs were finally 
precipitated with sodium acetate (final concentration of 
5% w/v in the sample) and then with 4 volumes of 
100% ethanol (EtOH) at 4°C overnight. Finally, 
samples were centrifuged at 2,000 xg and 4°C for 15 
min, supernatants discarded, pellets containing GAGs 
were dried and resuspended in H2O. 
 
GAGs quantification was performed using 
cetylpyridinium chloride (CPC) turbidimetry assay. 
Different dilutions of GAGs were prepared in a 96 well-
plate, alongside with CS-A (Sigma, concentration 
ranging from 0.02 to 5 µg) acting as standard curves. 
CPC reagent was prepared fresh by mixing one volume 
of 0.2% CPC with one volume of 133 mM magnesium 
chloride. Absorbance was measured at 405 nm with the 
software Gene5. Concentration of GAGs in the samples 
was quantified against the obtained standard curves.  
Fluorophore-assisted carbohydrate electrophoresis 
(FACE) 
 
GAGs extracted from each buffer in the previous step 
were digested into disaccharides with 0.1 U chABC 
(Sigma) in 100 mM ammonium acetate pH 8.0 for 2 h at 
37°C, then precipitated in four volumes of EtOH for 16 
h at 4°C. For C6S quantification, the samples were 
treated further with 50 mU of chondro-6-sulfatase 
(Seikagaku) for 1 hr. Subsequently, samples were 
centrifuged at 4°C and 18,000 xg for 5 min, and 
supernatants collected. The pellets were washed with 
EtOH and centrifuged for two more times. Supernatants 
from all the centrifuges were pooled and dried in a 
SpeedVac. The dried pellets were then derivatized with 
2-aminoacridone and sodium cyanoborohydride for 16 h 
at 37°C.  
 
0.5 µg of AMAC-conjugated disaccharide samples and 
standard disaccharides (5-20 ng of hyaluronic acid – 
HA, non-sulfated chondroitin - C0S, C4S, C6S; 
Seikagaku) were electrophoresed on a 30% 
polyacrylamide gel in Tris Glycine buffer (0.2 M 
Glycine, 2.5 mM EDTA, pH adjusted to 8.9 using 
Trizma Base) at 800 V until the dye front of phenol red 
exited the gel (30-40 min). 
 
For C4S, gels were imaged in a UV chamber (UVitec). 
Bands size and intensity were quantified using ImageJ 
software. The intensity of the sample data was 
normalized against the intensity of non-sulfated CS 
(C0S) and the quantity of disaccharides was calculated 
using the standard curve of HA electrophoresed in the 
same gel. Data are represented as ng of disaccharides 
per µg of GAGs analyzed. 
 
Chondroitin sulfotransferase (Chst) gene expression 
 
mRNA levels of the sulfotransferases involved in the 
formation of C4S and C6S were analyzed in 4 rats at 
ages 3,6,12 and 18 months. Brains were quickly 
dissected and frozen on dry ice. Subsequently, a piece 
of somatosensory cortex of about 4 mm side and 100 
mg weight was dissected on ice and collected in 
ribolyser tubes (Fastprep-24, Mpbio) with 1 ml of 
TRIzol Reagent (Invitrogen). Samples were spun three 
times for 20 sec at speed 5.5 in a Fastprep-24 5G 
machine. After homogenization, 200 µl of chloroform 
were added and samples centrifuged for 15 min at 
12,000 xg at 4°C. The aqueous phase was collected, 
another 200 µl of chloroform added, and centrifugation 
repeated. Samples were then diluted 1:1 in ice-cold 
isopropanol and centrifuged for 30 min at 4°C and 
maximum speed. The pellets were rinsed with EtOH 
70% and dried briefly at room temperature before being 
resuspended in RNAse free water. The RNA thus 
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obtained was treated with 20 U of DNAse-I (Roche) 
and 40 U of RNAse OUT (Invitrogen) in 3 M sodium 
acetate , pH4.0 and 0.5 M magnesium sulfate for 15 min 
at 37°C. RNA purification was performed with RNeasy 
Mini columns following manufacturer’s instructions 
(Qiagen). cDNA was synthesized from 1 µg of RNA by 
means of SuperScript III reverse transcription kit 
(Invitrogen), using Oligo(dT) primers and following the 
manufacturer’s protocol. 
 
Gene expression was analyzed by means of semi-
quantitative PCRs on samples of 300 ng of cDNA. The 
primers (Sigma) were either previously used [28] or 
newly designed to detect the expression of Chst11, 
Chst12, Chst13, responsible for the sulfation of C4S; 
and of Chst3, Chst7, responsible for the sulfation of 
C6S. Three PCRs with increasing number of cycles 
(cycle number selected to correspond to log phase of 
PCR reaction) were performed to quantify products of 
each set of primers. Glyceraldehyde-3-phosphate 
dehydrogenase (GADPH) was used as housekeeping 
gene. Primer sequences and details for each reaction are 
listed in Table 1. PCR products were electrophoresed 
for 1 h at 100 V (in a Scie-Plas chamber) on 1.5% 
agarose gel and were pictured in a UV chamber 
(UVitec) with constant parameters. Intensity of each 
picture was adjusted with Photoshop CS2 so that 
GAPDH bands were always saturated (255) and the 
bottoms of the wells were always black (0). Bands size 
and intensity were quantified with ImageJ software and 
normalized for the intensity of the 200 bp band of 
Hyperladder 50 bp (Bioline). Values obtained from the 
three increasing PCR of each sample were plotted on a 
logarithmic scale to calculate the exponential equation 
describing the expression of each gene. In every case, 
the cycle threshold (CT) was defined as the number of 
cycles needed to each sample for obtaining a band of 
intensity 2 on the logarithmic scale. For each gene, CTs 
calculated from animals of the same age were averaged. 
 
Culture of adult dorsal root ganglion neurons 
 
Coverslips were first coated overnight with poly-D-
lysine (40 µg/ml) in PBS, then washed and coated with 
2 µg/ml laminin and 25 µg/ml GAGs from the 
sequential extractions for 3 h. Some of the coverslips 
were subsequently treated with 0.1 U chABC (Sigma) 
for 2 h to digest the coated CS GAGs. Finally, 
coverslips were washed and preincubated at 37°C with 
medium (1% ITS, 1% PSF in DMEM; Gibco). 
 
Sprague Dawley rats of 3 months were humanely 
sacrificed and DRGs were dissected. The dissected 
DRG were cut into smaller pieces and incubated in 
collagenase (0.2% in Ca2+-free HBSS; Sigma) for 90 
min at 37°C, followed by the addition of trypsin (1 
Table 1. Sequences of PCR primers used to measure mRNA levels of sulfotransferases. 
Gene (enzyme) Primers sequence Cycles Product size (bp) 
Chst3 (CS6ST1) (F) 5’-TTCGTKGGSGAGTTCTTCAAC-3’ 
(R) 5’-CTCATAGCGCACCARCATGT-3’ 
25-28-31 674 
Chst7 (CS6ST2) (F) 5’-CCGATAGGCCCTTCCACTTG-3’ 
(R) 5’-CAGTTGGCGTTGGTTTCCAG-3’ 
25-28-31 205 
Chst11 (CS4ST1) (F) 5’-AAGTTCGAGGAGTTCGTGGC-3’ 
(R) 5’-CATCTCGTCGGTAGTTCGGG-3’ 
24-27-30 237 
Chst12 (CS4ST2) (F) 5’-TGGGAGGAAGACTGGTTTGC-3’ 
(R) 5’-AGGTGCTTGGGTTGTGTCAT-3’ 
24-27-30 259 
Chst13 (CS4ST3) (F) 5’-GCGTCCCGCATTTGAAAACA-3’ 
(R) 5’-ACGTAGCAGTACAGAAGCCG-3’ 
29-32-35 246 
GAPDH (F) 5’-TTCCAGTATGACTCTACCC-3’ 
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mg/ml; Sigma) at 37°C for 10 min. The DRG were then 
triturated, layered on 15% bovine serum albumin (BSA; 
Sigma) in medium (1% ITS, 1% PSF in DMEM) and 
centrifuged for 15 min at 1000 xg. The pellet containing 
DRG neurons was resuspended in culture medium (1% 
ITS, 1% PSF, 0.1 µg/ml NGF in DMEM) and 
centrifuged for 2 min at 2000 xg; supernatant discarded 
and pellet resuspended again. The dissociated DRG 
neurons were then cultured in the culture medium and 
kept in a 7% CO2 incubator. Cells were fixed for 10 min 
in warm 4% PFA at 24 h after plating, then kept at 4°C 
in PBS with 0.02% sodium azide until staining. 
 
Different experimental conditions tested were: laminin 
alone, ECM extracts (B1 GAGs) from 3 m rats and 18 
m rats, PNNs extracts (B4 GAGs) from 3 m rats and 18 
m rats.  
 
For the quantification of neurite length, neurons which 
are β3-tubulin positive and IB4 negative, and with cell 
diameter > 20 µm were imaged at 20X and the longest 
neurite per neuron was measured using ImageJ 
software. Data were averaged from three independent 





Data collected from animals of the same age were first 
tested for normal distribution and equal variance. If 
distributions were normal, data sets were compared by 
means of One Way ANOVA test, followed by 
Bonferroni or Dunnett post-hoc comparisons depending 
on homoscedasticity; the non-parametric Kruskal-
Wallis test was used instead when distributions were not 
normal. For the in vitro assay, although distribution 
were not normal, the number of observations was high 
enough to justify parametric statistics. All the data 
analyses were performed by using Excel 2010 and SPSS 
22. Unless otherwise specified, data are represented by 
means ± s.e.m. and tests results are considered 
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